المؤلفون: Finsterbusch K; Department of Surgical Pathology, Dietrich Bonhoeffer Klinikum, Allendestrasse 30, 17033, Neubrandenburg, Germany., van Diest PJ; Department of Pathology, University Medical Centre Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands., Focke CM; Department of Surgical Pathology, Dietrich Bonhoeffer Klinikum, Allendestrasse 30, 17033, Neubrandenburg, Germany. Cornelia.Focke@web.de.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 413-421. Date of Electronic Publication: 2024 Mar 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/metabolism , Immunohistochemistry* , Neoplasm Grading* , Receptors, Estrogen*/metabolism, Humans ; Female ; Receptor, ErbB-2/metabolism ; Receptor, ErbB-2/genetics ; Receptors, Progesterone/metabolism ; Middle Aged ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Adult ; Aged

المؤلفون: Criscitiello C; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy. carmen.criscitiello@ieo.it., Vingiani A; Pathology Department, IEO, European Institute of Oncology IRCCS, Milan, Italy., Maisonneuve P; Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy., Viale G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy., Viale G; Pathology Department, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Curigliano G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Sep; Vol. 183 (2), pp. 347-354. Date of Electronic Publication: 2020 Jul 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Biomarkers, Tumor/*immunology , Breast Neoplasms/*immunology , Chemotherapy, Adjuvant/*methods , Estrogen Receptor alpha/*metabolism , Lymphocytes, Tumor-Infiltrating/*immunology , Receptor, ErbB-2/*metabolism, Adult ; Aged ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Prognosis ; Receptors, Progesterone/metabolism ; Retrospective Studies ; Survival Rate

المؤلفون: Scatena C; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. cristian.scatena@unipi.it., Scarpitta R; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Innocenti L; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Miccoli M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Biancotti R; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Diodati L; Oncology Unit 2, Pisa University Hospital, Pisa, Italy., Ghilli M; Breast Surgery Unit, Pisa University Hospital, Pisa, Italy., Naccarato AG; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jul; Vol. 182 (1), pp. 55-65. Date of Electronic Publication: 2020 May 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Breast Neoplasms, Male/*pathology , Receptor, ErbB-2/*metabolism , Receptors, Androgen/*metabolism , Receptors, Estrogen/*metabolism , Receptors, Progesterone/*metabolism, Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms, Male/metabolism ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Staging ; Retrospective Studies

المؤلفون: Carene D; Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, Villejuif, France.; INSERM U981, Université Paris Sud, Villejuif, France., Tran-Dien A; INSERM U981, Université Paris Sud, Villejuif, France., Lemonnier J; R&D UNICANCER, Paris, France., Dalenc F; Institut Claudius Ragaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Levy C; Centre François Baclesse, Caen, France., Pierga JY; Institut Curie, Paris, France., Jacot W; Institut régional du Cancer de Montpellier, Montpellier, France., Canon JL; Grand Hôpital de Charleroi, Charleroi, Belgium., Richon C; Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France., Lacroix L; INSERM U981, Université Paris Sud, Villejuif, France.; Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France., Caux C; Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Centre Léon Bérard, 69008, Lyon, France., André F; Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, Villejuif, France.; INSERM U981, Université Paris Sud, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France. Stefan.michiels@gustaveroussy.fr.; CESP, Faculté de médecine, Université Paris Sud, Faculté de médecine UVSQ, INSERM, Université Paris Saclay, Villejuif, France. Stefan.michiels@gustaveroussy.fr.; Service de Biostatistique et d'Epidémiologie, Gustave Roussy and INSERM U1018, Université Paris Sud, 114 Rue Edouard Vaillant, 94800, Villejuif, France. Stefan.michiels@gustaveroussy.fr.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jan; Vol. 179 (2), pp. 387-401. Date of Electronic Publication: 2019 Oct 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor* , DNA Copy Number Variations* , Mutation*, Breast Neoplasms/*genetics , Breast Neoplasms/*mortality , MAP Kinase Kinase Kinase 1/*genetics , Receptor, Fibroblast Growth Factor, Type 1/*genetics, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Axilla/pathology ; Breast Neoplasms/diagnosis ; Breast Neoplasms/drug therapy ; Clinical Trials, Phase III as Topic ; Female ; Humans ; Lymph Nodes/pathology ; Lymphatic Metastasis ; MAP Kinase Kinase Kinase 1/metabolism ; Neoplasm Staging ; Prognosis ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/genetics ; Receptors, Progesterone/metabolism ; Treatment Outcome

المؤلفون: Krystel-Whittemore M; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Xu J; Department of Pathology, Memorial Sloan Kettering Cancer, 1275 York Avenue, New York, NY, 10065, USA., Brogi E; Department of Pathology, Memorial Sloan Kettering Cancer, 1275 York Avenue, New York, NY, 10065, USA., Ventura K; Department of Pathology, Memorial Sloan Kettering Cancer, 1275 York Avenue, New York, NY, 10065, USA., Patil S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer, New York, NY, USA., Ross DS; Department of Pathology, Memorial Sloan Kettering Cancer, 1275 York Avenue, New York, NY, 10065, USA., Dang C; Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY, USA., Robson M; Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY, USA., Norton L; Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY, USA., Morrow M; Department of Surgery, Memorial Sloan Kettering Cancer, New York, NY, USA., Wen HY; Department of Pathology, Memorial Sloan Kettering Cancer, 1275 York Avenue, New York, NY, 10065, USA. weny@mskcc.org.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Aug; Vol. 177 (1), pp. 61-66. Date of Electronic Publication: 2019 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*, Breast Neoplasms/*genetics , Breast Neoplasms/*therapy , Receptor, ErbB-2/*genetics, Adult ; Biopsy, Large-Core Needle ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Combined Modality Therapy ; Female ; Humans ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/genetics ; Receptors, Progesterone/metabolism ; Retrospective Studies ; Treatment Outcome

المؤلفون: Zhang LY; Department of Pathology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515031, People's Republic of China., Zhang YQ; Department of Breast Center, Cancer Hospital of Shantou University Medical College, No.7 Raoping Road, shantou, 515031, People's Republic of China.; Department of Breast-Thyroid-Surgery, Xiang'an Hospital of Xiamen University, 2000 Xiang'an East Road, Xiamen, 361101, People's Republic of China., Zeng YZ; Department of Pathology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515031, People's Republic of China., Zhu JL; Department of Pathology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515031, People's Republic of China., Chen H; Department of Pathology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515031, People's Republic of China., Wei XL; Department of Pathology, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515031, People's Republic of China. 466786230@qq.com., Liu LJ; Outpatient Department of Breast Center, Cancer Hospital of Shantou University Medical College, No. 7 Raoping Road, Shantou, 515031, People's Republic of China. 494206335@qq.com.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jul; Vol. 182 (1), pp. 21-33. Date of Electronic Publication: 2020 May 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Phosphatidylinositol 3-Kinases/*metabolism , Proto-Oncogene Proteins c-akt/*metabolism , Receptors, Estrogen/*metabolism , TRPC Cation Channels/*metabolism , Triple Negative Breast Neoplasms/*pathology, Apoptosis ; Biomarkers, Tumor/genetics ; Cell Movement ; Cell Proliferation ; Epithelial-Mesenchymal Transition ; Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic ; Humans ; Middle Aged ; Phosphatidylinositol 3-Kinases/genetics ; Prognosis ; Proto-Oncogene Proteins c-akt/genetics ; Receptor, ErbB-2/metabolism ; Receptors, Progesterone/metabolism ; TRPC Cation Channels/genetics ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/metabolism

المؤلفون: Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Rm 4443, Los Angeles, CA, 90089, USA. anna.wu@med.usc.edu., Tseng C; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Rm 4443, Los Angeles, CA, 90089, USA., Vigen C; Mrs. TH Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, USA., Yu Y; Global Data Science and Analytics- Medical Device Division, Abbott Laboratories, Santa Clara, CA, USA., Cozen W; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Rm 4443, Los Angeles, CA, 90089, USA., Garcia AA; Hematology Oncology, Louisiana State University School of Medicine, New Orleans, LA, USA., Spicer D; Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jul; Vol. 182 (2), pp. 451-463. Date of Electronic Publication: 2020 May 28.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Breast/*pathology , Breast Neoplasms/*epidemiology , Gastrointestinal Microbiome/*physiology, Adult ; Age Factors ; Aged ; Bacteroidetes/genetics ; Bacteroidetes/isolation & purification ; Body Mass Index ; Breast Neoplasms/pathology ; Breast Neoplasms/physiopathology ; Cross-Sectional Studies ; DNA, Bacterial/isolation & purification ; Feces/microbiology ; Female ; Firmicutes/genetics ; Firmicutes/isolation & purification ; Humans ; Menarche/physiology ; Middle Aged ; Parity/physiology ; Pilot Projects ; RNA, Ribosomal, 16S/genetics ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Risk Factors

المؤلفون: Almstedt K; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. katrin.almstedt@unimedizin-mainz.de., Mendoza S; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Otto M; Institute for Molecular Pathology, Trier, Germany., Battista MJ; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Steetskamp J; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Heimes AS; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Krajnak S; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Poplawski A; Institute of Medical Biometry, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany., Gerhold-Ay A; Institute of Medical Biometry, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany., Hasenburg A; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Denkert C; Institute of Pathology, Philipps-University Marburg and UKGM Marburg, Marburg, Germany., Schmidt M; Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jul; Vol. 182 (1), pp. 137-146. Date of Electronic Publication: 2020 May 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Decision-Making* , Gene Expression Profiling*, Biomarkers, Tumor/*genetics , Breast Neoplasms/*pathology , Receptor, ErbB-2/*metabolism , Receptors, Estrogen/*metabolism , Receptors, Progesterone/*metabolism, Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Carcinoma, Lobular/genetics ; Carcinoma, Lobular/metabolism ; Carcinoma, Lobular/pathology ; Decision Support Techniques ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Invasiveness ; Prognosis ; Retrospective Studies ; Risk Assessment ; Surveys and Questionnaires

المؤلفون: Li Y; Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Hongkou District, Shanghai, 200080, China., Qin J; Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Hongkou District, Shanghai, 200080, China., Wu J; Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Hongkou District, Shanghai, 200080, China., Dai X; Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Hongkou District, Shanghai, 200080, China., Xu J; Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Hongkou District, Shanghai, 200080, China. junmingxusur@hotmail.com.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jul; Vol. 182 (1), pp. 35-46. Date of Electronic Publication: 2020 May 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Breast Neoplasms/*pathology , Carcinoma, Ductal, Breast/*secondary , Carcinoma, Lobular/*secondary , Protein Serine-Threonine Kinases/*metabolism, Breast Neoplasms/metabolism ; Breast Neoplasms/therapy ; Carcinoma, Ductal, Breast/metabolism ; Carcinoma, Ductal, Breast/therapy ; Carcinoma, Lobular/metabolism ; Carcinoma, Lobular/therapy ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphatic Metastasis ; Middle Aged ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Retrospective Studies ; Survival Rate

المؤلفون: Hirakata T; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan., Fujii T; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan. ftakaaki@gunma-u.ac.jp.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan. ftakaaki@gunma-u.ac.jp., Kurozumi S; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan., Katayama A; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Japan., Honda C; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan., Yanai K; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan., Tokuda S; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan., Nakazawa Y; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan., Obayashi S; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan., Yajima R; Dvision of Breast and Endocrine Surgery, Graduate School of Medicine, Gunma University, Gunma, Japan.; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan., Kaira K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Japan.; Department of Innovative Immune-Oncology Therapeutics, Graduate School of Medicine, Gunma University, Gunma, Japan., Oyama T; Department of Diagnostic Pathology, Graduate School of Medicine, Gunma University, Gunma, Japan., Shirabe K; Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan.; Department of Innovative Immune-Oncology Therapeutics, Graduate School of Medicine, Gunma University, Gunma, Japan.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jun; Vol. 181 (2), pp. 331-338. Date of Electronic Publication: 2020 Apr 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: B7-H1 Antigen/*metabolism , Biomarkers, Tumor/*metabolism , Breast Neoplasms/*immunology , Breast Neoplasms/*metabolism , Fluorodeoxyglucose F18/*metabolism , Lymphocytes, Tumor-Infiltrating/*immunology, Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/pathology ; Carcinoma, Ductal, Breast/diagnostic imaging ; Carcinoma, Ductal, Breast/immunology ; Carcinoma, Ductal, Breast/metabolism ; Carcinoma, Ductal, Breast/pathology ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Invasiveness ; Positron-Emission Tomography ; Prognosis ; Radiopharmaceuticals/metabolism ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Retrospective Studies